Influenza Virus Inactivation for Studies of Antigenicity and Phenotypic Neuraminidase Inhibitor Resistance Profiling

• Published in: Journal of Clinical Microbiology 2010-03, Vol.48 (3), p.928-940
• Main Authors: Jonges, Marcel, Liu, Wai Ming, van der Vries, Erhard, Jacobi, Ronald, Pronk, Inge, Boog, Claire, Koopmans, Marion, Meijer, Adam, Soethout, Ernst
• Format: Article
• Language: English
• Subjects: Antiviral Agents - pharmacology; Biological and medical sciences; Containment of Biohazards - methods; Disinfection - methods; Female; Fundamental and applied biological sciences. Psychology; Humans; Influenza A virus - drug effects; Influenza A virus - physiology; Influenza A virus - radiation effects; Influenza virus; Influenza, Human - prevention & control; Male; Microbial Viability; Microbiology; Middle Aged; Miscellaneous; Neuraminidase - antagonists & inhibitors; Occupational Exposure - prevention & control; Orthomyxoviridae - drug effects; Orthomyxoviridae - immunology; Virology; Virus Inactivation
• ISSN: 0095-1137; 1098-660X
• DOI: 10.1128/JCM.02045-09

Introduction of a new influenza virus in humans urges quick analysis of its virological and immunological characteristics to determine the impact on public health and to develop protective measures for the human population. At present, however, the necessity of executing pandemic influenza virus research under biosafety level 3 (BSL-3) high-containment conditions severely hampers timely characterization of such viruses. We tested heat, formalin, Triton X-100, and β-propiolactone treatments for their potencies in inactivating human influenza A(H3N2) and avian A(H7N3) viruses, as well as seasonal and pandemic A(H1N1) virus isolates, while allowing the specimens to retain their virological and immunological properties. Successful heat inactivation coincided with the loss of hemagglutinin (HA) and neuraminidase (NA) characteristics, and β-propiolactone inactivation reduced the hemagglutination titer and NA activity of the human influenza virus 10-fold or more. Although Triton X-100 treatment resulted in inconsistent HA activity, the NA activities in culture supernatants were enhanced consistently. Nonetheless, formalin treatment permitted the best retention of HA and NA properties. Triton X-100 treatment proved to be the easiest-to-use influenza virus inactivation protocol for application in combination with phenotypic NA inhibitor susceptibility assays, while formalin treatment preserved B-cell and T-cell epitope antigenicity, allowing the detection of both humoral and cellular immune responses. In conclusion, we demonstrated successful influenza virus characterization using formalin- and Triton X-100-inactivated virus samples. Application of these inactivation protocols limits work under BSL-3 conditions to virus culture, thus enabling more timely determination of public health impact and development of protective measures when a new influenza virus, e.g., pandemic A(H1N1)v virus, is introduced in humans.